Antithrombotic Strategy for Patients with Acute Coronary Syndrome: A Perspective from East Asia

Dual antiplatelet therapy (DAPT) after percutaneous coronary intervention has become the standard of care, particularly in patients with acute coronary syndrome (ACS). Current clinical guidelines recommend novel P2Y12 inhibitors (e.g., prasugrel or ticagrelor) in addition to aspirin based on the res...

Descripción completa

Detalles Bibliográficos
Autores principales: Numasawa, Yohei, Sawano, Mitsuaki, Fukuoka, Ryoma, Ejiri, Kentaro, Kuno, Toshiki, Shoji, Satoshi, Kohsaka, Shun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356748/
https://www.ncbi.nlm.nih.gov/pubmed/32585929
http://dx.doi.org/10.3390/jcm9061963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356748/
https://www.ncbi.nlm.nih.gov/pubmed/32585929
http://dx.doi.org/10.3390/jcm9061963

Ejemplares similares